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suggest that early pre-emptive intervention is warranted in selected, asymptomatic individuals with aortic stenosis (AS). Other researchers have concluded that, in elderly patients with AS, a careful search for comorbidities and co existing cardiac diseases appeared relevant for accurate risk stratification and the choice of therapeutic strategy. 2 Although the proportion of asymptomatic patients in the series of Faggiano et al. was small (5.8%), we would like to draw attention to this great clinical challenge in the management and clinical decision-making process, [3] [4] [5] [6] [7] [8] because surgery for asymptomatic patients with AS is still controversial.
Current indications for aortic valve replacement (AVR) relate particularly to symptom development, but symptoms are typically insidious in onset and are masked by adjustments in lifestyle and a reduction in physical activity to avoid these manifestations. Many patients are unaware of subtle changes in effort tolerance (under-reporting of symptoms), and symptoms can be camouflaged by comorbidities such as pulmonary disease, obesity, peripheral artery disease and subsequent claudication, musculo skeletal degenerative diseases, the residual consequences of ischemic neurological events, poor eyesight or blindness, and physical deconditioning. Not surprisingly, these pathologies are common in the elderly. Thus, clinical evaluation of AS in the presence of heterogeneous associated diseases is rendered particularly complex. Serum B-type natriuretic peptide (BNP) levels have been demonstrated to predict symptom onset in asymptomatic adults with AS. 9 As a sensitive marker
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Is comorbidity equivalent to symptoms in asymptomatic AS? we support a strategy of early surgical intervention before symptom onset and consider asymptomatic patients, especially individuals aged >70-75 years, with the above mentioned comorbidities as having 'symptoms' in the evaluation of indications for surgery with treatment algorithms described in inter national guidelines. Our data favor minimally invasive AVR in elderly patients (overall in-hospital mortality 1.8% in patients aged >75 years). 10 We consider this approach a first-line strategy in such patients. If the individual is extremely frail and can not support or survive even minimally invasive AVR with the necessity for extracorporeal circulation and aortic cross-clamping, the most bland (almost 'hemi-conservative') tactics of those available today-transcatheter aortic valve implantation-might be offered as a second-line, reserve strategy.
In conclusion, we agree with Vaishnava and colleagues that a systematic, multidisciplinary diagnostic approach is beneficial for patients with severe AS, in which degenerative features are associated with advanced age and copathologies. Integral (global, or all-embracing) risk estimation must be performed throughout by the multi specialist team, including careful discussion of operative risk and life expectancy, long-term morbidity and mortality and quality-of-life, treatment preferences, and the probability of re operation. We even suggest that comorbidi ties in asymptomatic elderly patients could be considered to be 'symptom-equivalents' for prognostic stratification and thera peutic decision making, thanks to the widening spectrum of treatment options. 
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